9 results about "Tissue integration" patented technology

This invention discloses a bioactive glass and its preparation method, belonging to the field of bioactive glass technology. It aims to solve the problems of insufficient synergistic effect between antibacterial efficacy and bone-promoting activity in existing materials, as well as the inability to monitor in vivo degradation processes in real time. The bioactive glass comprises 44-48 parts silica; 22-27 parts calcium oxide; 22-27 parts sodium oxide; 5-7 parts phosphorus pentoxide; 2-4 parts europium zinc complex; 10-20 parts chitosan; 1-5 parts lidocaine; and 2-5 parts dilute acetic acid solution. The addition of the europium zinc complex promotes bone formation and enhances antibacterial activity, achieving a highly efficient synergy between anti-infection and tissue regeneration. Simultaneously, it provides optical tracking capabilities, allowing for non-destructive real-time monitoring of the material's degradation behavior and tissue integration in vivo via fluorescence imaging. This invention offers superior material performance and a simple preparation process, providing an innovative solution for the repair of infected bone defects.

This invention provides a medical repair membrane with an orthogonal crack-limiting structure and its preparation method. This invention relates to the field of biomedical materials technology. The medical repair membrane of this invention comprises at least two electrospun fiber layers, which intersect to form an orthogonal fiber structure. Layer B, facing tissue integration, adopts a coaxial core-shell structure. The shell layer contains biodegradable polymers and bioactive components, while the core layer is a biodegradable polymer. The structure of this invention effectively inhibits crack propagation and improves the structural stability of the material. Simultaneously, the core-shell structure enables controlled release of active components and tissue-selective induction, balancing mechanical properties and biocompatibility. The medical repair membrane is suitable for soft tissue defect repair, such as dura mater repair, fascia repair, pericardial repair, and hernia repair.

The application discloses a mineralized facial implant line and a preparation method thereof, and belongs to the technical field of medical implant materials. The method comprises the following steps: performing microphysical etching on the surface of a high-molecular implant line to form a uniform micro-pit structure; adsorbing a polydopamine film on the etched surface; performing biomimetic mineralization in a supersaturated calcium-phosphorus solution containing zinc ions to form a zinc-doped hydroxyapatite coating; and covalently grafting an enzyme-sensitive drug conjugate on the surface of the coating. The implant line prepared by the method has excellent biocompatibility, strong coating bonding force, good tissue integration capacity and intelligent drug release function, can effectively reduce inflammatory reactions and prevent line body displacement, and improves the durability and safety of facial lifting.

The application discloses a photocured biological tissue adhesive patch and a preparation method and application thereof, and relates to the technical field of biomedical materials. The photocured biological tissue adhesive patch comprises a composite polymer soluble microneedle, wherein the photocured biological tissue adhesive patch is prepared from a prepolymer solution comprising the following components: (1) methacrylated gelatin (GelMA); (2) oxidized dextran (ODex); (3) polyvinyl alcohol (PVA); and (4) a photoinitiator, wherein the photoinitiator comprises LAP; and the weight ratio of the methacrylated gelatin, the oxidized dextran, the polyvinyl alcohol and the photoinitiator is (5-10):(3-6):(3-8):(0.05-0.3). The photocured biological tissue adhesive patch has excellent tissue integration promotion effect, is particularly suitable for a conjunctival transplantation and other surgeries requiring high-quality tissue integration, has wide clinical application adaptability and good industrialization prospect.

This invention provides an electrospun gastric perforation patch based on Ag / Zn bimetallic MOF and its preparation method. The gastric perforation patch comprises a tissue integration layer, an antibacterial drug-loaded core layer, and an anti-adhesion layer integrally formed by electrospinning. The antibacterial drug-loaded core layer is composed of Ag / Zn bimetallic MOF loaded with antifungal drugs and a biodegradable polymer material. In the Ag / Zn bimetallic MOF, the molar ratio of zinc to silver is (8:1) to (12:1), and the antifungal drug is voriconazole or amphotericin B. This invention combines the broad-spectrum antimicrobial properties of Ag / Zn bimetallic MOF with a three-layer functional gradient design, enabling the patch to adhere firmly to tissue without sutures. It can actively prevent infection, inhibit adhesion, promote tissue regeneration, and gradually degrade and absorb postoperatively, significantly reducing the risk of foreign body reaction, infection, and recurrence, demonstrating excellent biocompatibility and broad clinical application prospects.

The application relates to the technical field of biology, and particularly discloses an artificial synthetic dermis loaded with subacromial synovial mesenchymal stem cell composite patch as well as a preparation method and application thereof. The artificial synthetic dermis loaded with subacromial synovial mesenchymal stem cell composite patch has the advantages of convenient raw material source, no immune rejection, no supply area complications, no disease transmission risk and the like. Moreover, the composite patch provides initial mechanical support, and improves the tendon-bone interface microenvironment through the paracrine effect (including pro-angiogenic related factors) of the subacromial synovial mesenchymal stem cells, promotes host cell infiltration and blood vessel ingrowth, and enhances tissue integration and rotator cuff healing.

The application discloses a multifunctional biomaterial for posterior sclera reinforcement, which is prepared by using layer-by-layer self-assembly (LbL) surface functionalization technology to coat silk fibroin (SF) on the surface of small intestinal submucosa (SIS), and preparing a light cross-linked SF (SFMA) microgroove coating with anisotropic characteristics on one side of the SIS for guiding cell arrangement and growth, promoting tissue regeneration and repair; and preparing a light cross-linked SF and sodium hyaluronate (SF-SH) mixed coating on the other side for improving biocompatibility and adhesion, so as to realize preparation of a multifunctional posterior sclera reinforcement biomaterial with controllable mechanical and degradation properties and capable of promoting surrounding tissue regeneration. The posterior sclera reinforcement biomaterial is cross-linked in the LbL mode to avoid toxic substance residues generated by cross-linking of SIS and traditional glutaraldehyde. The light cross-linked SFMA microgroove coating on one side can not only realize directional growth of fibroblasts, but also realize directional arrangement of collagen type I secreted by the cells, and effectively realize tissue integration. Meanwhile, the light cross-linked SF-SH mixed coating on the other side has excellent adhesion, which is helpful for positioning and attaching of the reinforcement material, and is of great significance to improving the effect of a posterior sclera reinforcement (PSR) operation and promoting long-term stable and effective treatment of pathological high myopia by using the biomaterial.

This invention discloses an implantable medical device comprising a polyethylene glycol diacrylate hydrogel matrix and monodisperse guanine peptide nucleic acid self-assembled microspheres immobilized within the polyethylene glycol diacrylate hydrogel matrix. The guanine peptide nucleic acid self-assembled microspheres exhibit a spatial quasi-periodic distribution within the hydrogel matrix characterized by short-range order and long-range disorder. This implantable medical device combines the light-harvesting advantages of biomimetic structures, the wide bandgap photoelectric properties of bio-organic semiconductors, and the flexible tissue integration capabilities of hydrogels to obtain an amorphous photonic crystal material with programmable optical properties and wide bandgap semiconductor properties. This product aims to achieve efficient, stable, and biosafe neurophotomodulation and, through mechanisms such as enhancing cortical gamma oscillations, effectively activating disease-related microglia in the hippocampus, and promoting the clearance of β-amyloid plaques, provides a novel, non-genetic, implantable optical therapy strategy for neurodegenerative diseases.

This invention discloses a multi-objective generation system and method for implantable biodegradable hydrogel sustained-release carriers in the biomedical field. By constructing a systematic generation architecture that integrates material component gradient design, dynamic modeling of mechanical response, and closed-loop regulation of biocompatibility, and through the synergistic effect of a triple mechanism of molecular-level crosslinking network topology reconstruction, degradation kinetic parameter coupling optimization, and active adaptation of the interface microenvironment, the degradation rate, structural strength maintenance ability, and tissue integration performance of the hydrogel are simultaneously and precisely controlled during its in vivo service life. This overcomes the technical defects of existing technologies, such as premature softening failure or aggravated local inflammatory response caused by single-dimensional regulation. It realizes the gradient design of the internal structure of the hydrogel from macro to micro, enabling the material to autonomously adjust its stiffness distribution according to the local stress state when subjected to complex physiological loads, avoiding the sudden mechanical collapse caused by the overall degradation of traditional homogeneous hydrogels.